Latest Press Releases

Health News Posted on Monday, December 11, 2017

Press Releases »

CVS Purchase of Aetna Highlights Critical Role of Consumer Experience in Healthcare and Branding, say CBX Experts

Branding veterans: Task at hand is for CVS to put consumer care first in ways that bolster loyalty and satisfaction; move to be closely watched in retail, healthcare and beyond, they say. NEW YORK , Dec. 11, 2017 /PRNewswire/ -- The pending $69 billion acquisition of Aetna by CVS could yie...

Read More ...

Janssen Submits Supplemental New Drug Application to FDA Seeking New Indications for XARELTO® (rivaroxaban) for Patients with Chronic Coronary and/or Peripheral Artery Disease (CAD/PAD)

Application seeks approval of the XARELTO® vascular dose (2.5mg BID) to reduce the risk of major cardiovascular events in patients with chronic CAD and/or PAD, and to reduce the risk of acute limb ischemia in patients with PAD ...

Read More ...

PharmaMar Presents Positive Results of the Pivotal Phase III Trial with Plitidepsin in Multiple Myeloma During the ASH Meeting

MADRID , December 11, 2017 /PRNewswire/ -- As previously informed, the Phase III trial, ADMYRE, which compared plitidepsin in combination with dexamethasone versus dexamethasone alone met its primary endpoint, progression free survival, and secondary objectives, overall survival and safety W...

Read More ...

Caris Life Sciences Identifies New Mechanism of Action for an Aptamer with Therapeutic Potential to Treat Non-Hodgkin Lymphoma

Study Presented at the 59th American Society of Hematology Annual Meeting & Exposition IRVING, Texas , Dec. 11, 2017 /PRNewswire/ -- Caris Life Sciences ® , a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced a data presentation, ...

Read More ...

Global Biosimilar Monoclonal Antibodies Market Revenue CAGR to Exceed 35.7% - Marketresearch.biz

NEW YORK , December 11, 2017 /PRNewswire/ -- MarketResearch.biz announces publication of its most recently generated research report titled, " Global Biosimilar Monoclonal Antibodies Market by Drug Class ( Rituximab, Infliximab, Abciximab, Trastuzumab, Adalimumab, and Bevacizumab ...

Read More ...

Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 2017

New Industry and Academic Partnerships Build on Company's Successes and Reinforce Vision for the Future RIDGEFIELD, Conn. and INGELHEIM, Germany , Dec. 11, 2017 /PRNewswire/ -- 2017 marks a year of significant advancement for Boehringer Ingelheim as it secured a range of external partnership...

Read More ...

Wellness Workdays Announces Best Wellness Employer Certification Program Developed with Leading Industry Experts

Initiative recognizes outstanding achievements of organizations committed to creating best-in-class corporate wellness programs ...

Read More ...

PharmaCielo Partner Cooperativa Caucannabis Announces Receipt of Cannabis Cultivation Licence

RIONEGRO, Colombia and TORONTO , Dec. 11, 2017 /PRNewswire/ -- PharmaCielo Colombia Holdings S.A.S. today announced that its Cauca department-based partner, Cooperativa Caucannabis, a collaborative of small growers, has received its licence for the cultivation of psychoactive cannabis from th...

Read More ...

Cardiome Highlights Partner SteadyMed's Agreement With FDA On Pathway To Trevyent NDA Resubmission

NDA Expected to be Filed and Accepted by the End of 2018 NASDAQ:CRME TSX:COM VANCOUVER , Dec. 11, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today highlighted that it...

Read More ...

TIBCO and Change Healthcare Partner to Accelerate Healthcare Transformation

Global Leaders Team Up to Help Payers and Providers Make Better Use of Health Data ...

Read More ...

Genomic Health Presents New Data Demonstrating Value of Oncotype DX® to Optimize Breast Cancer Outcomes and Reduce Treatment Burden throughout Disease Continuum

New Data Supports Expanded Use of Oncotype DX Breast Recurrence Score® Test for Predicting Treatment Benefit in Neoadjuvant Setting ...

Read More ...

OncoTartis Closes $6M Financing Round

Proceeds to Support Clinical Trials of Promising Cancer Treatment BUFFALO, N.Y. , Dec. 11, 2017 /PRNewswire/ -- OncoTartis, Inc., a biotechnology company developing a novel category of anti-cancer drugs, has concluded a $6 million financing round to support the Phase 1 clinical trial of it...

Read More ...

MilliporeSigma Signs Distribution Agreement with Avanti® Polar Lipids

- MilliporeSigma to distribute top lipid portfolio outside of United States ...

Read More ...

Global In-Vitro Diagnostic Instruments Market Revenue Expected to Expand at CAGR of 6.7% Over Next Ten Years - Marketresearch.biz

NEW YORK , December 11, 2017 /PRNewswire/ -- MarketResearch.biz announces publication of its most recently generated research report titled, " Global In-Vitro Diagnostic Instruments Market by Product Type (Immunochemistry, Clinical Microbiology, POCT, SMBG, Tissue Diagnostics,...

Read More ...

Synthetic Biology Market Set for 19.9% CAGR Explosive Growth to 2022 Led by Genome Engineering Technology | ReportsnReports

PUNE, India , December 11, 2017 /PRNewswire/ -- Synthetic Biology Market is forecast to reach $8.84 billion by 2022 from $3.57 billion in 2017 at a CAGR of 19.9% during (2017-2022) driven by the wide range of applications of synthetic biology, rising R&D funding and initiatives, increa...

Read More ...

Regen BioPharma, Inc. Files Additional Composition of Matter Patent Application on NR2F6-Modulating Small Molecules

SAN DIEGO , December 11, 2017 /PRNewswire/ -- Regen BioPharma, Inc. (OTCQB: RGBP) and (OTCQB: RGBPP) today announced filing a patent application covering composition of matter and methods of use related to molecules identified in its small molecule program that activate and inhibit NR2F6 ("Sma...

Read More ...

Merck Signs Distribution Agreement with Avanti® Polar Lipids

- Merck to distribute top lipid portfolio outside of United States - Improves customer access through e-commerce platform DARMSTADT, Germany , Dec. 11, 2017 /PRNewswire/ --  Merck , a leading science and technology company, today announced that it has entered into an agreement with Avan...

Read More ...

Healthcare Staffing Market Worth $43.6 Billion By 2025 | CAGR: 5.4%: Grand View Research, Inc.

SAN FRANCISCO , December 11, 2017 /PRNewswire/ -- The global  healthcare staffing market  is expected to reach USD 43.6 billion by 2025, according to a new report by Grand View Research, Inc. Rising geriatric population has increased the demand for healthcare services around the globe. How...

Read More ...

Medigene Collaborates with RXi Pharmaceuticals to Further Sharpen its Therapeutic T cells

- Synergies between the recombinant T cell technologies of Medigene and self-delivering RNAi technologies from RXi Pharmaceuticals will be explored preclinically MARLBOROUGH, Mass. , Dec. 11, 2017 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII) announced today that it has ente...

Read More ...

PhaseRx Commences Voluntary Chapter 11 Bankruptcy Protection Proceeding

SEATTLE , Dec. 11, 2017 /PRNewswire/ -- PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical company developing mRNA treatments for life-threatening inherited liver diseases in children, today announced that it has elected to file a voluntary petition under Chapter 11 of the Bankruptcy Code in the...

Read More ...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Helius Medical Technologies, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

NEW YORK , Dec. 11, 2017 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Helius Medical Technologies, Inc. (OTC: HSDT). ...

Read More ...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating XOMA Corporation for Potential Breaches Of Fiduciary Duty By Its Board of Directors

NEW YORK , Dec. 11, 2017 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of XOMA Corporation (NASDAQ: XOMA). If you are a ...

Read More ...

Wahoo Fitness Premieres on Deloitte's 2017 Technology Fast 500(TM) Companies in North America

Leader in connected fitness devices attributes strong revenue growth to innovation and delivering user-centric products to the market ATLANTA , Dec. 11, 2017 /PRNewswire/ --  Wahoo Fitness , the leader in connected fitness devices, today announced it has premiered on the Deloitte Fast 500™, ...

Read More ...

Regeneron Announces FDA Acceptance of sBLA Filing for 12-Week Dosing of EYLEA® (aflibercept) Injection for Patients with Wet AMD

TARRYTOWN, N.Y. , Dec. 11, 2017 /PRNewswire/ --  Regeneron Pharmaceuticals, Inc.  (NASDAQ:  REGN ) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's supplemental Biologics License Application (sBLA) for a 12-week dosing interval of EYLEA ® (...

Read More ...

Prometic's PBI-4050 Receives Promising Innovative Medicine (PIM) Designation From The UK MHRA In The Treatment Of Idiopathic Pulmonary Fibrosis

LAVAL, QC , Dec. 11, 2017 /PRNewswire/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) (Prometic) announced today that its orally-active drug candidate, PBI-4050, has been issued a Promising Innovative Medicine (PIM) designation by the United Kingdom (UK) Medicines and Healthcare Prod...

Read More ...

Global Medical Tourism Market Value to Reach US$160.8 billion by the End of 2025: Transparency Market Research

Global Medical Tourism Market: Patients and Families to Seek Medical Care in Emerging Nations as Healthcare Costs Soar in Developed Countries, Says TMR ALBANY, New York , December 11, 2017 /PRNewswire/ -- Exhibiting a remarkable growth over the last few years, the global medical tourism mar...

Read More ...

Attunity Wins $1 Million of Additional Business with Fortune 100 Healthcare Company to Enable Strategic Hadoop Data Lake Initiative

Customer's second large order for Attunity Replicate provides ability to scale data ingestion from hundreds of disparate data sources for analytics BURLINGTON, Massachusetts , December 11, 2017 /PRNewswire/ -- Attunity Ltd. (NASDAQ CM: ATTU), a leading provider of data integration and Big D...

Read More ...

Stock Review for Biotech's Investors -- Cyclacel Pharma, Capricor Therapeutics, Cymabay Therapeutics, and BioDelivery Sciences

NEW YORK , December 11, 2017 /PRNewswire/ -- In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has issued free tailored Stock Review on CYCC, CAPR, CBAY, and BDSI which is a click away at www.wallstequities.com/registration . On Friday,...

Read More ...

FDA Accepts Biologics License Application (BLA) to Review Galcanezumab for the Prevention of Migraine in Adults

Galcanezumab is the first of three investigational, non-opioid treatments in Lilly's pain portfolio ...

Read More ...

Quotidian Technical Highlights on Selected Healthcare Stocks -- Quidel, PetMed Express, Valeant Pharma, and Aradigm

NEW YORK , December 11, 2017 /PRNewswire/ -- In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has issued free tailored Stock Review on QDEL, PETS, VRX, and ARDM which is a click away at http://www.wallstequities.com/registration . Marke...

Read More ...

Technical Perspectives on Palatin Technologies, Atossa Genetics, DBV Technologies, and IDEXX Labs

NEW YORK , December 11, 2017 /PRNewswire/ -- In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has issued free tailored Stock Review on PTN, ATOS, DBVT, and IDXX which is a click away at http://www.wallstequities.com/registration . Today...

Read More ...

Eating Yogurt May Help Reduce Chronic Inflammation in Women, New Clinical Trial Reveals

New study shows eating low-fat yogurt on a regular basis reduces biomarkers in women of chronic inflammation - a hallmark of obesity, cardiovascular disease and type 2 diabetes ...

Read More ...

Cardiome Announces Xydalba™ Treatment And Patient Experience Presentations At The 2017 National Opat Conference

NASDAQ:CRME TSX:COM Plenary Symposium Features Three Experts Discussing Clinical Use VANCOUVER , Dec. 11, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, specialty pharmaceutical company focused on commercializing patent-protected hospital drugs, to...

Read More ...

Anti-venom Market Value to Reach US$2,946 Million by the End of 2025: Transparency Market Research

Global Anti-venom Market: Research and Studies Conducted at International Level Pushes Growth Prospects, says TMR ALBANY, New York , December 11, 2017 /PRNewswire/ -- Presence of several enterprises has rendered the global anti-venom market highly fragmented. In a new study, Transparency Ma...

Read More ...

ApolloMed And Network Medical Management Announce Completion Of Merger And Listing On The Nasdaq Capital Market

MERGER CREATES ONE OF THE LARGEST POPULATION HEALTH MANAGEMENT PLATFORMS IN THE U.S. GLENDALE, Calif. , Dec. 11, 2017 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed" or "the Company") (NASDAQ: AMEH), an integrated population health management company, and Network Medical Managem...

Read More ...

Anytime Fitness Flexes Development Plans for Mississippi

Fastest-Growing Global Gym Looks to Add 25 New Locations by 2020 ...

Read More ...

Exscientia Appoints Alex Snow, Founder of Oxford Innovation Sciences and Former CEO of Lansdowne Partners, as Deputy Chairman

OXFORD, England and DUNDEE, Scotland , December 11, 2017 /PRNewswire/ -- Exscientia, the innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is pleased to announce the appointment of Mr Alex Snow to its Board of Directors as Deputy Chairman. He brings...

Read More ...

Xultophy® Significantly Reduces Blood Sugar Levels, Body Weight and Risk of Hypoglycaemia for People With Type 2 Diabetes in Real-World Setting

BAGSVÆRD, Denmark , December 11, 2017 /PRNewswire/ -- Results published in Diabetes, Obesity and Metabolism     Newly published data from real-world European clinical practice has shown that Xultophy ® (insulin degludec/liraglutide) significantly reduced blood sugar levels in people with ...

Read More ...

Doctors at Fortis Hospitals, Cunningham Road Successfully Treated a Severe Dengue Struck Patient

BANGALORE , December 11, 2017 /PRNewswire/ -- 37-year-old had brain damage and was in coma for 30 days   Doctors at Fortis Hospitals, Cunningham road successfully treated a 37-year-old male patient who was suffering from severe brain damage and coma as a result of dengue fever. The dengu...

Read More ...

Betalutin® Shows Strong Clinical Profile in Relapsed/refractory Indolent NHL and Follicular Lymphoma

Updated data reported at the 59th Annual American Society of Hematology (ASH) meeting Location Phone Number   Norway   +47-2350-0296   Switzerland   +41-44-580-1022   Sweden   +46-8-5065-3942   United   Kingdom and International ...

Read More ...
More Press Releases

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store